Back to blog

    Imaging Data Standardization: A Practical Guide for Trials and Research

    Technologist preparing a participant for MRI

    Imaging data standardization means making images and the information attached to them look, read and measure the same way no matter which scanner, site or vendor produced them. It happens at four levels: how images are acquired, how the DICOM metadata is labeled, how measurements and reports are expressed, and how data from many sites is harmonized into one dataset. Done early, it keeps variability out of your endpoints. Done late, it becomes an expensive cleanup. At KoHealth Labs we bundle laboratory and imaging data for clinical research, so this is the workflow we think sponsors and CROs should plan around from protocol design.

    Kohealth Labs
    Coordinate Lab Support for Research
    KoHealth Labs supports clinical studies with laboratory testing, specimen management, and solutions tailored to study-specific requirements.

    TL;DR

    • Standardize in four layers: acquisition protocol, DICOM metadata, measurement and reporting vocabulary, and multi-site harmonization.
    • The FDA’s imaging guidance for trials centers on acquisition, display, archiving and interpretation standards, and it encourages an imaging charter that documents them.
    • DICOM gives you a common file format, but scanner hardware, reconstruction settings and site habits still create differences you must control.
    • Data prepared for AI needs de-identified metadata, machine-readable structure and a mix of vendors and populations, or models will not generalize.
    • Our integrated lab and radiology data bundles are designed to deliver analysis-ready data aligned to regulatory requirements.

    What imaging data standardization covers

    A scan is two things at once: pixels and the description of how those pixels were made. In DICOM, the international format for medical images, metadata and pixel data are embedded in a single file so the image can never be separated from its information by mistake. That metadata records the patient, the study, the scanner and the acquisition settings.

    Standardization is the work of making those two halves comparable across sources. The FDA’s guidance on clinical trial imaging endpoint process standards (April 2018) frames the purpose as helping sponsors optimize the quality of imaging data used to support drug and biologic approval, with a focus on acquisition, display, archiving and interpretation when imaging assesses a primary endpoint or a component of it.

    For the people reading this, the question is rarely “what is DICOM.” It is usually one of these:

    • A sponsor or CRO asking why imaging readouts from twenty sites do not line up.
    • A trial designer deciding how much imaging control a protocol needs.
    • A research institution preparing a dataset for statistical or AI analysis.
    • A government or health organization that needs consistent imaging data for reporting.

    Why it matters for endpoints

    The FDA guidance states that standardization becomes essential when an imaging endpoint is used in a trial, to reduce variability and ensure the results can be interpreted. It also notes that the extent of trial-specific standardization depends on how standardized local practice already is. Routine bone X-rays need less added control than bone mineral density measurements, for example.

    That last point is a useful planning rule. Before you write the imaging section of a protocol, rank each imaging measure by how much site-to-site variation it can tolerate. The more quantitative the endpoint, the more you should standardize.

    Layer 1: Acquisition protocols

    The most expensive variability is created before the scan is saved. A 2026 JMIR Medical Informatics review of real-world imaging data points out that although DICOM standardizes the file format, substantial variability persists in practice. Scanner hardware, tube voltage, slice thickness, contrast timing and reconstruction choices such as kernel selection and iterative reconstruction all produce systematic differences in image appearance and quantitative measurements across sites and vendors.

    The FDA guidance lists what sponsors should weigh when setting acquisition standards:

    1. Which imaging modalities are available at sites, and how technical performance varies between them.
    2. The qualifications of the technologists who will acquire the images.
    3. Whether the proposed measures depend on phantoms or calibration standards.
    4. Image quality control standards.
    5. Procedures for displaying and interpreting images.

    Where it goes wrong: protocols are written for the ideal site. A site with an older scanner or a different vendor quietly substitutes settings, and the difference only appears when the central read or statistics show unexplained noise. Check site capability during feasibility, not after first patient in.

    The imaging charter

    The FDA encourages sponsors to develop an imaging charter when existing medical imaging practice should be augmented. The charter details trial-specific imaging process standards and describes how sources of bias and variability are controlled and how the standards are implemented to a level appropriate to the trial design. Our guide on turning FDA guidance into site checks with an imaging charter walks through how to make that document operational rather than shelf-ware.

    Layer 2: DICOM metadata

    Even with a good protocol, metadata arrives messy. Patient names are mistyped, procedure descriptions are free text, and laterality is sometimes wrong. The DICOM standard itself anticipates this. Its section on metadata updates says that a PACS (picture archiving and communication system) may update patient, order and procedure data and series- and instance-level information as part of quality control, with examples including correcting a patient name, changing a patient ID, updating procedure descriptions or codes to a standard format, and correcting body part laterality.

    The DICOM Standard’s Part 3 information model is built on a data dictionary that registers each data element, which is what makes rule-based normalization possible: you decide how each element must look, then check every incoming study against it.

    A workable normalization routine has these parts:

    • Governed rules. Written mappings for modality, body part, series description and procedure codes.
    • Identity safeguards. Controls that prevent a corrected ID from merging two patients.
    • Continuous quality monitoring. Counts of missing or out-of-range tags per site, tracked over time.
    • An exception workflow. A named owner and a turnaround target for studies that fail the rules.
    • An audit trail. Every change recorded, so a regulator or monitor can trace a value back to its source.

    One design choice matters here. Some curation systems, such as the Posda database described in 2018, store DICOM as it actually arrives and determine conformance through queries, so a parseable dataset is never discarded just for failing a rule. That keeps the original evidence intact while you correct a working copy, a principle worth borrowing for any trial archive.

    For trial teams, the metadata that matters most is the acquisition parameters that explain measurement differences: modality, body part examined, slice thickness and reconstruction settings. The Medical Imaging Common Data Model proposed in 2024 structures exactly these DICOM tags and links them to standardized clinical data, documenting the provenance of derived features as well.

    Layer 3: Common vocabulary for measurements and reports

    Standard files do not guarantee standard meaning. Two radiologists can describe the same finding in different words. Common Data Elements (CDEs) address this. A CDE is a question, concept, measurement or feature with controlled responses, and the ASNR-ACR-RSNA project building a neuroradiology catalog says adopting them can let imaging report data be compared across institutions locally, regionally and nationally.

    This extends to AI output. A 2025 study in the Journal of Imaging Informatics in Medicine describes using CDEs with DICOM Structured Reporting to embed AI-derived results in radiology reports, so findings stay consistent and interoperable across health systems.

    For sponsors, structured reporting is also the bridge to submission datasets. Two of our guides cover that path: how to map DICOM imaging data to SDTM and five checks for traceable DICOM SR mapping.

    Layer 4: Harmonizing data across sites

    When many sites contribute, you need a central step that checks, cleans and aligns everything before analysis. Two large US programs show the pattern.

    The National Alzheimer’s Coordinating Center’s SCAN initiative aims to harmonize PET and MRI acquisition across its research centers. Centers upload SCAN-compliant images to a hosted portal, where they are de-identified and defaced, and PET and MRI laboratories then process them for quality assurance and harmonization.

    The National Cancer Institute’s Imaging Data Commons takes a format-first approach. According to its 2023 RadioGraphics description, all hosted images and image-derived data are natively DICOM or harmonized into DICOM, and that choice lets it use off-the-shelf commercial and open source tools, lowering development and maintenance costs and allowing reuse of analysis components.

    The lesson for a trial is the order of operations:

    Step What happens What it prevents
    Site qualification Confirm scanners, technologists and phantom or calibration use Protocol drift at the source
    Intake check Validate required DICOM tags on arrival Missing parameters found months later
    De-identification Remove protected health information from metadata and pixels Privacy exposure and rejected transfers
    Normalization Apply governed rules to codes, descriptions and laterality Unusable groupings and failed queries
    Quality review Review exceptions with an audit trail Silent corrections nobody can trace
    Delivery Provide analysis-ready data in the agreed structure Rework by biostatistics

    Our article on radiology data QC for research teams covers the quality-control layer in more depth.

    Preparing standardized imaging data for AI

    Research groups and sponsors increasingly want imaging data that can train or validate algorithms. The steps are well described in a review on preparing medical imaging data for machine learning: local ethics approval is typically required, relevant data must be accessed, queried, de-identified and securely stored, protected health information must be removed from DICOM metadata and images, and the data should be structured in homogenized, machine-readable formats linked to ground truth.

    The same review names two biases that standardization helps manage. An algorithm trained on images from one institution may lose performance in a different population, which is population or disease-prevalence bias. One trained on a single kind of machine may not work as well on other manufacturers’ machines, which is vendor or single-source bias. A multi-site dataset that is harmonized but still contains a range of vendors addresses both.

    Preparing standardized imaging data for AI

    The Quantitative Imaging Network’s 2020 review adds documentation practices: record the acquisition protocol and potential confounders, keep the provenance of annotations and analysis results, and use unique identifiers to prevent cross-contamination between training and testing data. It also observes that most research formats lack standardized metadata and a common data model, which is why DICOM remains the practical choice for integrating research tools with the data they generate.

    A short checklist before you start

    1. Rank each imaging endpoint by how much variability it can tolerate.
    2. Survey site scanners and technologist experience during feasibility.
    3. Write the imaging charter and tie each requirement to a site check.
    4. Define the required DICOM tags and the rules that normalize them.
    5. Decide who owns exceptions and how fast they must be resolved.
    6. Specify the delivery format, including how imaging links to laboratory and clinical data.
    7. Plan de-identification and provenance recording from day one.

    If you run a multi-physician practice, FQHC or hospital outpatient clinic rather than a trial, the same logic applies at a smaller scale: consistent order codes and results flowing into your EMR keep imaging and lab information comparable over time.

    Why a combined lab and imaging partner simplifies this

    Imaging rarely stands alone in a study. Biomarker results, specimen logistics and radiology readouts need to line up by subject and visit. When they come from separate vendors, someone has to reconcile identifiers, formats and delivery schedules. Our approach is to integrate laboratory diagnostics and radiology services, so imaging and lab data can be bundled for a study, with onboarding and training for the teams involved.

    We design our AI-driven, analysis-ready data bundles for regulatory-aligned delivery, supported by EMR integration and specimen pickup across test panels that span 100+ biomarkers, genomics and imaging. For study design, our trial designer’s guide to integrated radiology shows where imaging decisions belong in the protocol.

    Promo

    If you are planning a study where imaging and laboratory data must arrive together, in a structure your statisticians can use, talk with our clinical research team. We offer clinical trial laboratory services with specimen management, biomarker analysis and bundled lab and imaging data built around study-specific requirements. See our clinical trials page for how we support CROs and sponsors.

    Kohealth Labs

    Practices and health organizations looking for a primary or additional diagnostic laboratory can start from our home page.

    Our perspective

    Standardization is easiest to afford at the start of a study and hardest to afford at the end. Every site that deviates from the imaging charter, every unmapped procedure code and every identifier that does not match a laboratory record becomes a query someone must resolve by hand.

    We believe the answer is fewer handoffs. When laboratory testing, specimen logistics and radiology data are planned together, the subject identifiers, visit schedules and delivery formats are agreed once. That is why we build bundled, analysis-ready data around the study protocol, with onboarding and training so site teams know what is expected.

    Our commitment is to speed, reliability, flexibility and direct communication. For a sponsor, that means a partner who answers questions about data structure before the first scan, not after database lock.

    Kohealth Labs

    FAQ

    What is the difference between DICOM and imaging data standardization?

    DICOM is the file format and communication standard for medical images, and it embeds metadata with the pixels. Standardization is the broader effort to make the content consistent: acquisition settings, tag values, vocabulary and harmonization across sites. DICOM makes it possible, but practice still varies between scanners and sites.

    Do all trials need an imaging charter?

    The FDA encourages one when existing medical imaging practice standards should be augmented for the trial. The more your primary endpoint depends on imaging, and the less standardized local procedures are, the more detail the charter should carry.

    How does standardization help AI development?

    It produces homogenized, machine-readable data with clean metadata and documented provenance. Combined with images from varied vendors and populations, it reduces the single-source and prevalence biases that limit how well algorithms perform on new data.

    Can imaging data be linked to laboratory results?

    Yes, when subject and visit identifiers are agreed from the start. Linking imaging to structured clinical data is the idea behind common data models for imaging, and it is the reason we plan laboratory and radiology data together for research studies.

    Sources

    For more information about our diagnostic testing, clinical research laboratory services, or partnership opportunities, visit https://kohealthlabs.com or contact KoHealth Labs at (469) 792-8439 and ask for Amy Patterson.